July 07, 2015

MEDTECH FISCAL 2015 REVENUE INCREASES 130% TO $7.9 M

Montpellier, France, July 7, 2015 – MEDTECH (Euronext, FR0010892950 – ROSA), a company specialized in designing, developing and marketing innovative surgical assistance robots, announced revenue results for its fiscal fourth quarter and full year ended June 30, 2015. For fiscal year 2015, the Company reported a 130% increase in revenue to $7.9 million.

Read more

 

Montpellier, France, July 7, 2015 – MEDTECH (Euronext, FR0010892950 – ROSA), a company specialized in designing, developing and marketing innovative surgical assistance robots, announced revenue results for its fiscal fourth quarter and full year ended June 30, 2015. For fiscal year 2015, the Company reported a 130% increase in revenue to $7.9 million.

In thousand of Dollars 2013/2014 2014/2015
Q4 Revenue (April 1 - June 30) 1589 3766
Annual Revenue (July 1 - June 30) 3435 7893

 

As of June 30, 2015, Medtech had a total fleet of 48 ROSA® robots worldwide, including 21 in North America, 15 in Europe and 12 in other parts of the world, in line with its market development plans.

During the fiscal year ended June 30, 2015, Medtech sold 20 ROSA® robots throughout the world, including 13 in the United States.

In the fiscal fourth quarter (April 1 - June 30, 2015), Medtech sold 10 ROSA® robots (including 5 in the United States and also the first ROSA® Spine in Europe), recording a revenue of $3.8 million, up 137% compared with the same period in the previous financial year.

“We are very pleased with this excellent commercial performance. Sales of ROSA® robots continued to increase significantly from quarter to quarter throughout fiscal 2015 as we began to benefit from our investments in expanding our global sales and marketing infrastructure and regulatory clearances. The Company is successfully executing on its commercial development strategy and is well positioned for continued long-term growth, particularly with the recent launch of ROSA® Spine in Europe and the pending U.S. regulatory clearance,” said Bertin Nahum, President and Founder of Medtech.